These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8946477)

  • 21. Inhibition kinetics of monoclonal antibodies against cytochromes P450.
    Mei Q; Tang C; Lin Y; Rushmore TH; Shou M
    Drug Metab Dispos; 2002 Jun; 30(6):701-8. PubMed ID: 12019198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast.
    Ellis SW; Ching MS; Watson PF; Henderson CJ; Simula AP; Lennard MS; Tucker GT; Woods HF
    Biochem Pharmacol; 1992 Aug; 44(4):617-20. PubMed ID: 1510710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.
    Halliday RC; Jones BC; Smith DA; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1995 Oct; 40(4):369-78. PubMed ID: 8554939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 isoforms responsible for the N-deethylation and cyclohexane-hydroxylation of NS-21.
    Nakamura A; Hirota T; Morino A; Imaoka S; Funae Y; Yamamoto Y; Tasaki T; Masuda M; Kazusaka A; Fujita S
    Xenobiotica; 1999 Mar; 29(3):243-52. PubMed ID: 10219965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.
    Beulz-Riché D; Grudé P; Puozzo C; Sautel F; Filaquier C; Riché C; Ratanasavanh D
    Fundam Clin Pharmacol; 2005 Oct; 19(5):545-53. PubMed ID: 16176333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of CYP2D1 in the metabolism of carteolol by male rat liver microsomes.
    Umehara K; Kudo S; Odomi M
    Xenobiotica; 1997 Nov; 27(11):1121-9. PubMed ID: 9413916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.
    Natsui K; Mizuno Y; Tani N; Yabuki M; Komuro S
    Eur J Drug Metab Pharmacokinet; 2007; 32(3):131-7. PubMed ID: 18062405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation.
    Kudo S; Odomi M
    Eur J Clin Pharmacol; 1998 May; 54(3):253-9. PubMed ID: 9681669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.
    Volotinen M; Turpeinen M; Tolonen A; Uusitalo J; Mäenpää J; Pelkonen O
    Drug Metab Dispos; 2007 Jul; 35(7):1135-41. PubMed ID: 17431033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.
    Hutchinson MR; Menelaou A; Foster DJ; Coller JK; Somogyi AA
    Br J Clin Pharmacol; 2004 Mar; 57(3):287-97. PubMed ID: 14998425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
    Ewald AH; Maurer HH
    Toxicol Lett; 2008 Dec; 183(1-3):52-7. PubMed ID: 18938231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine.
    Kirkwood LC; Nation RL; Somogyi AA
    Br J Clin Pharmacol; 1997 Dec; 44(6):549-55. PubMed ID: 9431830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-Hydroxylation of debrisoquine by human CYP1A1 and its inhibition by quinidine and quinine.
    Granvil CP; Krausz KW; Gelboin HV; Idle JR; Gonzalez FJ
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1025-32. PubMed ID: 12023534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes.
    Narimatsu S; Kobayashi N; Masubuchi Y; Horie T; Kakegawa T; Kobayashi H; Hardwick JP; Gonzalez FJ; Shimada N; Ohmori S; Kitada M; Asaoka K; Kataoka H; Yamamoto S; Satoh T
    Chem Biol Interact; 2000 Jun; 127(1):73-90. PubMed ID: 10903420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin.
    Haritos VS; Ghabrial H; Ahokas JT; Ching MS
    Pharmacogenetics; 2000 Oct; 10(7):591-603. PubMed ID: 11037801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
    Barham HM; Lennard MS; Tucker GT
    Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes.
    Crewe HK; Ellis SW; Lennard MS; Tucker GT
    Biochem Pharmacol; 1997 Jan; 53(2):171-8. PubMed ID: 9037249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro characterization of cytochrome P450 2D6 inhibition by classic histamine H1 receptor antagonists.
    Hamelin BA; Bouayad A; Drolet B; Gravel A; Turgeon J
    Drug Metab Dispos; 1998 Jun; 26(6):536-9. PubMed ID: 9616188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.